People: Greatbatch Inc (GB)

GB on New York Consolidated

48.14USD
17 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$48.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
127,287
52-wk High
$51.64
52-wk Low
$39.51

Search Stocks

Bihl, Anthony 

Brief Biography

Mr. Anthony P. Bihl, III, is an Independent Director of Greatbatch, Inc., since 2011. Mr. Bihl is currently Group President AMS, a subsidiary of Endo Pharmaceuticals, which acquired American Medical Systems Holdings (“AMS”) in June 2011, a position from which he has announced he will step down in July 2012. Prior to the acquisition by Endo, he was Chief Executive Officer and a director of AMS, a company engaged in developing and delivering medical technology solutions to physicians treating men’s and women’s pelvic health conditions. Mr. Bihl served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics Division from January to November 2007, and as President of the Diagnostics Division of Bayer HealthCare from 2004 through 2006. Prior to that, he served in a number of operations and finance roles at Bayer Healthcare and over a 20-year career at E.I. DuPont. He also is a director of Spectral Diagnostics, Inc., a Canadian company that develops products for the diagnosis and treatment of severe sepsis and septic shock.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bill Sanford

--

Thomas Hook

3,414,480

Michael Dinkins

1,367,990

Andrew Holman

--

Mauricio Arellano

1,254,470

George Cintra

--
As Of 2 Jan 2014
Search Stocks